Synageva BioPharma's Merger

Synageva BioPharma raised a round of funding on November 21, 2011. Investors include Trimeris.

Synageva BioPharma is dedicated to discovering, developing and delivering medicines for patients with rare diseases and unmet medical need. The Company has developed a pipeline of therapeutic products…

Articles about Synageva BioPharma's Merger: